share_log

CVS Health | 8-K: Current report

CVS Health | 8-K: Current report

西維斯健康 | 8-K:重大事件
美股SEC公告 ·  12/09 04:11

Moomoo AI 已提取核心訊息

CVS Health announced the results of its cash tender offer for any and all of its 4.100% Senior Notes due 2025. As of December 6, 2024, $225,979,000 principal amount was validly tendered, with an additional $5,000 tendered under guaranteed delivery procedures. The settlement date is expected to be December 11, 2024.CVS Health plans to accept all validly tendered notes for purchase. The tender offer will be funded using proceeds from the issuance of new junior subordinated notes. The company also announced a concurrent Maximum Tender Offer for other notes, with a maximum purchase price of $2 billion less the amount paid for the 2025 Notes.The tender offers are part of CVS Health's ongoing efforts to manage its debt profile. As of September 30, 2024, the company operated over 9,000 retail locations, 900+ walk-in clinics, and served approximately 90 million pharmacy benefits members, showcasing its significant presence in the healthcare sector.
CVS Health announced the results of its cash tender offer for any and all of its 4.100% Senior Notes due 2025. As of December 6, 2024, $225,979,000 principal amount was validly tendered, with an additional $5,000 tendered under guaranteed delivery procedures. The settlement date is expected to be December 11, 2024.CVS Health plans to accept all validly tendered notes for purchase. The tender offer will be funded using proceeds from the issuance of new junior subordinated notes. The company also announced a concurrent Maximum Tender Offer for other notes, with a maximum purchase price of $2 billion less the amount paid for the 2025 Notes.The tender offers are part of CVS Health's ongoing efforts to manage its debt profile. As of September 30, 2024, the company operated over 9,000 retail locations, 900+ walk-in clinics, and served approximately 90 million pharmacy benefits members, showcasing its significant presence in the healthcare sector.
西維斯健康宣佈其對任何及所有到期於2025年的4.100%高級票據的現金投標結果。截至2024年12月6日,有效投標的本金金額爲225,979,000美元,另有5,000美元根據擔保交付程序進行投標。預計結算日期爲2024年12月11日。西維斯健康計劃接受所有有效投標的票據進行購買。投標將使用新發行的次級後付票據的收益進行融資。該公司還宣佈了一項與之同時進行的其他票據的最大投標,最高購買價格爲20億減去爲2025年票據支付的金額。這些投標是西維斯健康持續努力管理其債務結構的一部分。截至2024年9月30日,公司運營超過9,000個零售網點,900多個步入式診所,服務約9000萬藥房福利會員,展示了其在醫療保健板塊的重要存在。
西維斯健康宣佈其對任何及所有到期於2025年的4.100%高級票據的現金投標結果。截至2024年12月6日,有效投標的本金金額爲225,979,000美元,另有5,000美元根據擔保交付程序進行投標。預計結算日期爲2024年12月11日。西維斯健康計劃接受所有有效投標的票據進行購買。投標將使用新發行的次級後付票據的收益進行融資。該公司還宣佈了一項與之同時進行的其他票據的最大投標,最高購買價格爲20億減去爲2025年票據支付的金額。這些投標是西維斯健康持續努力管理其債務結構的一部分。截至2024年9月30日,公司運營超過9,000個零售網點,900多個步入式診所,服務約9000萬藥房福利會員,展示了其在醫療保健板塊的重要存在。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息